Doctor profile · Federal record
Dr. MOHAMMAD ALAM, MD
Infectious Disease Physician (CMS: INFECTIOUS DISEASE) · Internal Medicine Physician · SHREVEPORT, LA
- NPI 1255399622
- Accepts Medicare
- 48 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1501 KINGS HWY
SHREVEPORT, LA 711034228
(318) 675-4881
fax (318) 675-5069 - Mailing address
-
832 ELMWOOD ST
SHREVEPORT, LA 711044802
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- March 28, 2017
- Year of graduation
- 1978 — 48 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Louisiana #MD.08670R
- Medicaid
- LA #1933872
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1255399622. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
416
Distinct HCPCS
7
Medicare allowed
$49,070
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 220 | 76 | $114 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 69 | 63 | $167 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 46 | 30 | $95 | |
99285 |
Emergency department visit with high level of medical decision making | 31 | 30 | $176 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | 22 | $8 | |
99284 |
Emergency department visit with moderate level of medical decision making | 14 | 14 | $114 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 13 | 11 | $64 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 308. This provider delivers 1.4× the peer median.Open Payments
Industry payments received
All-time total
$1,155
Transactions
55
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 12 | $272.05 | |
| Merck Sharp & Dohme LLC | 12 | $240.91 | |
| Astellas Pharma US Inc | 5 | $175.10 | |
| Shionogi Inc | 10 | $151.51 | |
| Insmed, Inc. | 4 | $72.86 | |
| Melinta Therapeutics, LLC | 2 | $56.05 | |
| Gilead Sciences, Inc. | 3 | $51.46 | |
| ViiV Healthcare Company | 2 | $41.45 | |
| Paratek Pharmaceuticals, Inc. | 2 | $41.15 | |
| La Jolla Pharmaceutical Company | 2 | $35.59 | |
| AIMMUNE THERAPEUTICS, INC. | 1 | $17.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
79
Patients
11
Total drug cost
$284,810
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 54 | 11 | $220,432 |
| Descovy (Emtricitabine/Tenofov Alafenam) | Brand | 14 | 0 | $32,374 |
| Tivicay (Dolutegravir Sodium) | Brand | 11 | 0 | $32,004 |